Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2026-01-13 @ 11:15 PM
Study NCT ID:
NCT01914367
Status:
COMPLETED
Last Update Posted:
2022-12-09
First Post:
2013-06-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®)
Sponsor:
University Hospital, Ghent
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2013/422
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None